Treatment and outcome of pediatric intracranial ependymoma after first relapse Zhi-ming LiuZhe HanYong-ji Tian Clinical Study 28 February 2022 Pages: 385 - 396
Multisession radiosurgery for grade 2 (WHO), high risk meningiomas. A phase II clinical trial Marcello MarchettiValentina PinziLaura Fariselli Clinical Study 04 April 2022 Pages: 397 - 403
Contrast enhancing pattern on pre-treatment MRI predicts response to anti-angiogenic treatment in recurrent glioblastoma: comparison of bevacizumab and temozolomide treatment Hye Hyeon MoonJi Eun ParkHo Sung Kim Clinical Study 11 March 2022 Pages: 405 - 415
A volume matched comparison of survival after radiosurgery in non-small cell lung cancer patients with one versus more than twenty brain metastases Zhishuo WeiAjay NiranjanL. Dade Lunsford Clinical Study 22 March 2022 Pages: 417 - 423
Disease Control after Radiotherapy for Adult Craniopharyngioma: Clinical Outcomes from a Large Single-Institution Series Michael S. RutenbergAdam L. HoltzmanRobert J. Amdur Clinical Study 12 March 2022 Pages: 425 - 433
Transcranial magnetic stimulation for post-operative neurorehabilitation in neuro-oncology: a review of the literature and future directions Evan H. EinsteinNicholas B. DadarioRandy S. D’Amico Topic Review 25 March 2022 Pages: 435 - 443
Correction to: Transcranial magnetic stimulation for post-operative neurorehabilitation in neuro-oncology: a review of the literature and future directions Evan H. EinsteinNicholas B. DadarioRandy S. D’Amico Correction 19 April 2022 Pages: 445 - 445
Managing cancer and living meaningfully (CALM) in adults with malignant glioma: a proof-of-concept phase IIa trial Ashlee R. LoughanKelcie D. WillisLeroy Thacker Clinical Study 18 April 2022 Pages: 447 - 456
Quantifying intraventricular drug delivery utilizing programmable ventriculoperitoneal shunts as the intraventricular access device Sheila S. McTheniaNeeta Pandit-TaskarKim Kramer Clinical Study 11 April 2022 Pages: 457 - 463
The posterior fossa syndrome questionnaire: using science to inform practice Molly E. WickenhauserRaja B. KhanHeather M. Conklin Clinical Study 05 April 2022 Pages: 465 - 473
Supportive care of patients diagnosed with high grade glioma and their carers in Australia Georgia K. B. HalkettMelissa N. BergAnna K. Nowak Clinical Study Open access 09 April 2022 Pages: 475 - 485
The burden of a brain tumor: guiding patient centric care in neuro-oncology Ashlee R. LoughanMorgan ReidKaren Lo Research 08 April 2022 Pages: 487 - 498
DICER1 mutations in primary central nervous system tumors: new insights into histologies, mutations, and prognosis Kevin X. LiuHelen H. ShangDaphne A. Haas-Kogan Research 06 April 2022 Pages: 499 - 510
Gyriform infiltration as imaging biomarker for molecular glioblastomas Emmanuel MesnyMarc BarritaultFrançois Ducray Clinical Study 01 April 2022 Pages: 511 - 521
Diaph3 underlines tumor cell heterogeneity in glioblastoma with implications for treatment modalities resistance George S. StoyanovEmran LyutfiPeter Ghenev Research 05 April 2022 Pages: 523 - 531
Immune-related aseptic meningitis and strategies to manage immune checkpoint inhibitor therapy: a systematic review Simon NanniniLarysa KoshenkovaRoland Schott Topic Review Open access 13 April 2022 Pages: 533 - 550
Lacosamide in monotherapy in BTRE (brain tumor-related epilepsy): results from an Italian multicenter retrospective study F. MoS. MelettiR. Rudà Clinical Study 09 April 2022 Pages: 551 - 559
MGMT gene promoter methylation by pyrosequencing method correlates volumetric response and neurological status in IDH wild-type glioblastomas Tomohiro HosoyaMasamichi TakahashiYoshitaka Narita Clinical Study Open access 10 April 2022 Pages: 561 - 571
Comment on "The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study" George S. Stoyanov Correspondence 05 April 2022 Pages: 573 - 574
NSG-70, a new glioblastoma cell line with mixed proneural-mesenchymal features, associates NOTCH1-WNT5A signaling with stem cell maintenance and angiogenesis Divya Kumari SinghPavan Kumar Mysuru ShivalingappaSharmila A. Bapat Research 17 April 2022 Pages: 575 - 591
Retraction Note to: LncRNA RP11-84E24.3 drives tumorigenesis and epithelial-to-mesenchymal transition of glioma cells by promoting TFAP2C-mediated activation of SNAI1 Lisha ChangJingyue WangJiang Zhang Retraction Note 28 April 2022 Pages: 593 - 593
